WideCells Group PLC (LON:WDC), the healthcare services company focused on providing stem cell services and ground-breaking insurance for stem cell treatment, is delighted to announce its five-year anniversary today.
WideCells Group was established in order to transform the stem cell industry by creating the first end-to-end service solutions to make stem cell treatment accessible and affordable globally. Having recognised a need and identified an opportunity to change the way in which stem cell services are provided globally, Chief Executive Officer João Andrade and Chief Operating Officer Lopes Gil founded the company. Since its inception, WideCells Group has made formidable progress in creating a dynamic, revenue generative business, which is now listed on the London Stock Exchange. The significant progress made by the Group has resulted in WideCells Group being ranked as the 21st most disruptive company globally by DISRUPT 100 and being nominated as the Life Sciences IPO of the Year 2016 by Biotech & Money.
The Group’s service offering spans three synergistic divisions:
CellPlan Limited has successfully created and launched the world’s first stem cell healthcare insurance plan – CellPlan. Recognising that whilst over 3 million people worldwide have paid c.£2,000 to store stem cells, the Group discovered that many were unaware that the cost to use stem cells in treatment can be up to £300,000. Accordingly, the Group set out to remove cost barriers by creating CellPlan, which for an average price of £170 per annum provides financial cover for medical treatment, travel and accommodation expenses, an expert medical opinion and a concierge service to manage the stem cell treatment process. The product is now available for purchase in the UK having secured strategic commercial agreements with the UK’s largest private human tissue storage facility Biovault Technical Ltd (‘Biovault’). The Company is also due to launch an e-commerce platform shortly and has signed an agreement to supply customers in Brazil via Hemocord Clinica Medica Ltd, a world-class leader in cord blood storage.